Teva Pharmaceutical Industries Ltd.

Director's Dealing • Mar 6, 2024

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

(Print or Type Responses)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(th) of the Investment Company Act of 1940

1. Name and Address of Reporting Person Weiss Amir	2. Issuer Name and Ticker or Trading Symbol Teva Pharmaceutical Industries Limited TEVA	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner
(Last) (First) (Middle) C/O Teva Pharmaceutical Industries Ltd. 124 Dvora HaNevi'a St.,	3. Date of Earliest Transaction (Month/Day/Year) 03/03/2024	X Officer (give title below) Other (specify below) Chief Accounting Officer
(Street) Tel Aviv, L3 6944020 (City) (State) (Zip)	4. If Amendment, Date Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security	2. Transaction	2A. Deemed	3. Transaction		4. Securities Acquired			5. Amount of Securities Beneficially		7. Nature
(Instr. 3)	Date	l Execution Date, if Code			(A) or Disposed of (D)			Owned Following Reported	Ownership of Indirect
	(Month/Day/Year) any		(Instr. 8)			(Instr. 3, 4 and 5)		Transaction(s)	Form:	Beneficial
		ا (Month/Day/Year)						(Instr. 3 and 4)		Direct (D) Ownership
									or Indirect (Instr. 4)
						(A) or			(1)
			Code		Amount	D)	Price		(Instr. 4)
'Ordinary Shares (1)	03/03/2024		M		5,179	A	(2)	19,074	D
'Ordinary Shares (1)	03/04/2024		M		10.676	A	(2)	29,750	D

	Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)

				Online of the comments of the first of the first of the first of the first of the first of the first of the first of the first of the first for the first and the final the f
1. Title of	2.	3. Transaction	3A. Deemed	ব	5. Number of		6. Date Exercisable		7. Title and Amount			8. Price of 9. Number of	10	11. Nature
Derivative	Conversion Date		Execution Date, if Transaction Derivative				and Expiration Date		of Underlying			Derivative Derivative		Ownership of Indirect
Security		or Exercise (Month/Day/Year) any		Code	Securities		(Month/Day/Year)		Securities		Security	Securities	Form of	Beneficial
(Instr. 3)	Price of		(Month/Day/Year) (Instr. 8)						(Instr. 3 and 4)		(Instr. 5)	Beneficially	Derivative	Ownership
					Acquired (A) or
	Derivative				Disposed of (D)							Owned	Security:	(Instr. 4)
	Security				(Instr. 3, 4, and 5)							Following	Direct (D)
							Date Exercisable Date	Expiration	Title	Amount or Number of		Reported Transaction(s) (Instr. 4)	or Indirect (1) (Instr. 4)
				Code	(A)	(D)				Shares
Restricted Share Units	(2)	03/03/2024		M		5,179	(3)	(3)	Ordinary Shares (1)	5,179	\$ 0	15,538	D
Restricted Share Units	(2)	03/04/2024		M		10,676	(4)	(4)	Ordinary Shares (1)	10,676	\$ 0	21,355	D
Restricted Share Units	(2)	03/04/2024		A	22,600		(ર)	(5)	Ordinary Shares (1)	22,600	\$ 0	22,600	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. 1. Each restricted share unit represents a continent, one ordinary share or at the option of the Human Resources and Compensation Committee, the cash valle of one ordinary share.
3. 1. Resurced share units were granted on March 3, 2024, March 3, 2024, March 3, 2024, March 3, 2026, and 5, 180 vesing on March 3, 2127,
4. 1. Restinced stare units were grand on March 4, 2023 and Mach 4, 2024, 10, 675 vesing on Mach 4, 2025 and 10,679 vesting on March 4, 2026,
5. 1. Restricted share units were granted on March 4, 2024, with 5,650 vesting on each of March 4, 2021, March 4, 2027, and March 4, 2028.

Signatures

/s/ Dov Bergwerk as attorney-in-fact for Amir Weiss 03/05/2024

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly.

• * If the form is filed by more than one reporting person, see Instruction 4(b)(v).
• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 18tf(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of in this form are not required to respond unless the form displays a currently valid OMB Number.